← FDA DRUG APPROVALS

FDA NDA · NDA205383

ORALTAG

Sponsor: INTERPHARMA PRAHA AS

APPLICATION
NDA205383
TYPE
NDA
ORIGINAL APPROVAL
2015-03-26
LATEST ACTION
2015-03-26
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued

Products

ORALTAGDiscontinued
IOHEXOL 9.7GM/BOT · FOR SOLUTION · ORAL

Approval history

2015-03-26Type 3 - New Dosage Form · Original · standardPediatric Medical ReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →